Alnylam Pharmaceuticals, Inc. (ALNY)
397.65
+0.40
(+0.10%)
USD |
NASDAQ |
Dec 31, 16:00
397.66
+0.01
(+0.00%)
After-Hours: 20:00
Alnylam Pharmaceuticals Research and Development Expense (TTM): 1.248B for Sept. 30, 2025
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| Biogen, Inc. | 1.524B |
| Insmed, Inc. | 695.91M |
| Pfizer Inc. | 10.13B |
| Glaukos Corp. | 143.49M |
| BridgeBio Pharma, Inc. | 465.89M |